Scarica l'app Stockscreener
6.51
4.83%
0.30
Dopo l'orario di chiusura:
6.50
-0.010
-0.15%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CAPR Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.21
Aprire:
$6.4
Volume 24 ore:
1.42M
Relative Volume:
1.08
Capitalizzazione di mercato:
$297.62M
Reddito:
$27.10M
Utile/perdita netta:
$-24.31M
Rapporto P/E:
-7.8434
EPS:
-0.83
Flusso di cassa netto:
$-33.33M
1 W Prestazione:
+5.00%
1M Prestazione:
-9.71%
6M Prestazione:
-48.74%
1 anno Prestazione:
-67.61%
Intervallo 1D:
$6.16
$6.54
Intervallo di 1 settimana:
$6.12
$7.08
Portata 52W:
$5.68
$20.75
Capricor Therapeutics Inc Stock (CAPR) Company Profile
Nome
Capricor Therapeutics Inc
Settore
Industria
Telefono
(310) 358-3200
Indirizzo
10865 ROAD TO THE CURE, SAN DIEGO, CA
Confronta CAPR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CAPR
Capricor Therapeutics Inc
|
6.51 | 283.90M | 27.10M | -24.31M | -33.33M | -0.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Capricor Therapeutics Inc Stock (CAPR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-30 | Iniziato | Alliance Global Partners | Buy |
| 2025-06-26 | Iniziato | B. Riley Securities | Buy |
| 2025-05-20 | Iniziato | Roth Capital | Buy |
| 2024-10-21 | Iniziato | Piper Sandler | Overweight |
| 2024-05-17 | Iniziato | Oppenheimer | Outperform |
| 2024-01-05 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-10-26 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-12-26 | Downgrade | Maxim Group | Buy → Hold |
| 2018-01-26 | Reiterato | H.C. Wainwright | Buy |
| 2017-09-15 | Reiterato | H.C. Wainwright | Buy |
| 2017-02-13 | Ripresa | Rodman & Renshaw | Buy |
| 2016-07-06 | Ripresa | H.C. Wainwright | Buy |
| 2016-06-15 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Capricor Therapeutics Inc Borsa (CAPR) Ultime notizie
Chart overlay techniques for tracking Capricor Therapeutics Inc.Quarterly Portfolio Summary & Stepwise Trade Signal Implementation - newser.com
Capricor Therapeutics Inc.’s volatility index tracking explained2025 Retail Activity & Low Drawdown Trading Techniques - newser.com
What insider purchases suggest about Capricor Therapeutics Inc. (4LN2) stockWeekly Trade Review & Real-Time Buy Signal Notifications - newser.com
Smart tools for monitoring Capricor Therapeutics Inc.’s price actionProfit Target & Daily Technical Forecast Reports - newser.com
Is it too late to sell Capricor Therapeutics Inc.Market Movers & Community Driven Trade Alerts - newser.com
Chart based analysis of Capricor Therapeutics Inc. trendsJuly 2025 Retail & Safe Capital Preservation Plans - newser.com
HBK Sorce Advisory LLC Increases Stake in Capricor Therapeutics, Inc. $CAPR - MarketBeat
Capricor Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - newser.com
Price momentum metrics for Capricor Therapeutics Inc. explainedWeekly Volume Report & AI Powered Market Entry Ideas - newser.com
Is Capricor Therapeutics Inc. (4LN2) stock a momentum leaderJuly 2025 Snapshot & Entry and Exit Point Strategies - newser.com
Will Capricor Therapeutics Inc. (4LN2) stock see insider accumulationJuly 2025 Earnings & Fast Entry and Exit Trade Plans - newser.com
Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10 - The Manila Times
Capricor Therapeutics to Announce Third Quarter 2025 Financial Results on November 10, 2025 - Quiver Quantitative
Capricor (NASDAQ: CAPR) schedules financial results call for Nov 10 at 4:30 p.m. ET - Stock Titan
Will Capricor Therapeutics Inc. (4LN2) stock outperform energy sector in 2025July 2025 Selloffs & Safe Entry Point Identification - newser.com
We're Hopeful That Capricor Therapeutics (NASDAQ:CAPR) Will Use Its Cash Wisely - Yahoo Finance
What technical charts say about Capricor Therapeutics Inc. stockEarnings Growth Summary & AI Driven Stock Movement Reports - newser.com
How big funds are accumulating Capricor Therapeutics Inc. (4LN2) stockPortfolio Performance Report & Free Fast Gain Swing Trade Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Capricor Therapeutics, Inc. (CAPR) And Encourages Investors to Reach Out - ACCESS Newswire
Capricor (CAPR) Moves 12.0% Higher: Will This Strength Last? - Yahoo Finance
What institutional flow reveals about Capricor Therapeutics Inc.Inflation Watch & Consistent Return Investment Signals - newser.com
Will Capricor Therapeutics Inc. price bounce be sustainable2025 Fundamental Recap & Short-Term High Return Strategies - newser.com
Kuehn Law Encourages Investors of Capricor Therapeutics, Inc. to Contact Law Firm - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Capricor Therapeutics, Inc. (CAPR) And Encourages Stockholders to Reach Out - ACCESS Newswire
What dividend safety rating applies to Capricor Therapeutics Inc. (4LN2) stockQuarterly Profit Report & Accurate Intraday Trading Signals - fcp.pa.gov.br
Capricor Therapeutics Inc Azioni (CAPR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):